Managed Health Care

Clover Health Investments

Clover Health Investments released FY2026 Q1 earnings on May 6 After-Market EST, actual revenue USD 749.19 M (forecast USD 714.89 M), actual EPS USD 0.0499 (forecast USD 0.0295)

Clover Health Investments to Release FY2026 Q1 Earnings on May 6 After-Market EST, Forecast Revenue USD 714.89 M, EPS USD 0.0295

Clover Health Investments released FY2025 Q4 earnings on February 26 After-Market EST, actual revenue USD 487.71 M (forecast USD 467.06 M), actual EPS USD -0.0953 (forecast USD -0.1021)

Clover Health Investments released FY2025 annual earnings on February 26 After-Market (EST), actual revenue USD 1.924 B (forecast USD 1.904 B), actual EPS USD -0.17 (forecast USD -0.1729)

Clover Health Investments to Release FY2025 Q4 Earnings on February 26 After-Market EST, Forecast Revenue USD 467.06 M, EPS USD -0.1021

Clover Health Reports Q3 Earnings with 35% Membership Growth and Nearly 50% Revenue Growth

Clover Health CEO sells company stock

Clover Health Investments released FY2025 9 Months earnings on November 4, 2025, After-Market (EST), actual revenue USD 1.437 B, actual EPS USD -0.0733

Clover Health Investments released FY2025 Q3 earnings on November 4 After-Market (EST), actual revenue USD 495.85 M (forecast USD 471.08 M), actual EPS USD -0.0475 (forecast USD -0.0285)

Clover Health projects 42.3% revenue growth to $471M in Q3

Counterpart Health Publishes Whitepaper on AI-based Tool

Clover Health Investments to release FY2025 Q3 earnings on November 4 After-Market EST, forecast revenue USD 471.08 M, EPS USD -0.0285

Clover Health Announces 2026 Medicare Plan

Clover Health's Subsidiary Counterpart Health Expands AI HEDIS Platform to Third-Party Partners

Hewitt Analyst Recommends Healthcare Industry Stocks

Counterpart Health Launches AI-Based Environmental Logging Solution

Clover Health CEO Testifies on AI-driven Healthcare Transformation

Clover Health Investments' Former CEO Purchases $1 Million in Stock

Clover Health Quarterly Earnings Fall Short of Expectations, Stock Price Drops

Clover Health Investments released FY2025 Semi-Annual earnings on August 5 After-Market EST, actual revenue USD 939.95 M, actual EPS USD -0.0232

Optimi Health

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Clover Health Investments (CLOV.US) Q2 2025 Earnings Conference Call

Clover Health Investments (CLOV.US) Q1 2025 Earnings Conference Call

Clover Health Investments (CLOV.US) Q4 2024 Earnings Conference Call

Clover Health Investments (CLOV.US) Q3 2024 Earnings Conference Call

GRAB

CLOV

The article discusses three elite penny stocks that are well-positioned to withstand rising interest rates and inflation. Grab Holdings operates a multi-service superapp in Southeast Asia, showing improving profitability but facing risks related to external funding and earnings quality. Marqeta provides a cloud-based platform for card management, experiencing significant growth but reliant on a few major clients. Clover Health Investments offers Medicare Advantage plans, leveraging technology for chronic condition management, yet faces ongoing losses and reliance on external borrowing. Investors should weigh the potential rewards against the associated risks for each stock.

Simplywall

Grab

Marqeta

GRAB - CW25

3 Elite Penny Stocks With Strength To Withstand Higher Rates

Earnings Watch

Clover Health Investments | 8-K: FY2026 Q1 Revenue: USD 749.19 M

Clover Health is set to report earnings this Wednesday, with expectations of a 54.6% year-on-year revenue growth, following a previous quarter where it beat revenue estimates with $487.7 million. Analysts have maintained their estimates, indicating confidence in the company's performance. Despite past misses on revenue estimates, Clover Health's stock has risen 41.5% recently, with an average analyst price target of $2.82. Comparatively, peers like Centene and Elevance Health have shown positive results, contributing to a favorable sentiment in the health insurance sector.

Stock Story

Centene

Elevance Health

Clover Health Earnings: What To Look For From CLOV

Clover Health Investments (NASDAQ:CLOV) is set to announce its Q1 2026 earnings on May 6, with expectations of $0.07 per share and $714.89 million in revenue. The company previously reported a loss of $0.10 per share for Q4 2025. Analysts have mixed ratings on the stock, with a consensus rating of "Hold" and an average target price of $2.90. CEO Brady Priest recently sold 175,000 shares, reducing his ownership by 8.05%. Institutional investors hold 19.77% of the company's stock, which focuses on Medicare Advantage plans for seniors.

Market Beat

Hims & Hers Health

Virtu Finc

Clover Health Investments (CLOV) Expected to Announce Quarterly Earnings on Wednesday

WRBY

The U.S. market has risen 3.4% in the past week and 30% over the last year, with projected earnings growth of 16% annually. Companies with high insider ownership, such as Coastal Financial, Clover Health, and Warby Parker, are highlighted for their strong growth potential. Coastal Financial is expected to grow earnings by 44.2% annually, while Clover Health forecasts 77.5% growth despite recent losses. Warby Parker anticipates 61.8% earnings growth as it transitions to profitability. All three companies are trading below their estimated fair values, indicating potential for stock price appreciation.

Clover Health Investments(CLOV.US)

3 Elite Penny Stocks With Strength To Withstand Higher Rates

Clover Health Investments | 8-K: FY2026 Q1 Revenue: USD 749.19 M

Clover Health Earnings: What To Look For From CLOV

Clover Health Investments (CLOV) Expected to Announce Quarterly Earnings on Wednesday

Coastal Financial And 2 Other Growth Companies With Strong Insider Confidence

Clover Health Announces CFO Transition and Reaffirms 2026 Outlook